Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients (Q44574707)

4 December 2017

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients (English)

1 reference

4 December 2017

0 references

0 references

9

Harald Hampel

1 reference

4 December 2017

11

Kaj Blennow

1 reference

4 December 2017

5

Lennart Minthon

1 reference

4 December 2017

8

Hans Jürgen Möller

1 reference

4 December 2017

2

Kina Höglund

1 reference

4 December 2017

3

Magnus Sjögren

1 reference

4 December 2017

7

Katharina Buerger

1 reference

4 December 2017

10

Pia Davidsson

1 reference

4 December 2017

6

Lars Lannfelt

1 reference

4 December 2017

Annika Olsson

1

1 reference

PubMed ID

12957490

4 December 2017

Niels Andreasen

series ordinal

4

1 reference

PubMed ID

12957490

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

Experimental Neurology

1 reference

4 December 2017

183

1 reference

4 December 2017

1

1 reference

4 December 2017

74-80

1 reference

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Membrane protein secretases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Regulation of amyloid precursor protein cleavage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Role of neurotransmission in the regulation of amyloid beta-protein precursor processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Mild cognitive impairment: clinical characterization and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Quantitative changes in the amyloid βA4 precursor protein in Alzheimer cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2803%2900027-X

10.1016/S0014-4886(03)00027-X

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

12957490